Literature DB >> 16982728

Cancer's molecular sweet tooth and the Warburg effect.

Jung-whan Kim1, Chi V Dang.   

Abstract

More than 80 years ago, the renowned biochemist Otto Warburg described how cancer cells avidly consume glucose and produce lactic acid under aerobic conditions. Recent studies arguing that cancer cells benefit from this phenomenon, termed the Warburg effect, have renewed discussions about its exact role as cause, correlate, or facilitator of cancer. Molecular advances in this area may reveal tactics to exploit the cancer cell's "sweet tooth" for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982728     DOI: 10.1158/0008-5472.CAN-06-1501

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  467 in total

Review 1.  Staying alive: metabolic adaptations to quiescence.

Authors:  James R Valcourt; Johanna M S Lemons; Erin M Haley; Mina Kojima; Olukunle O Demuren; Hilary A Coller
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

Review 2.  The role of mitochondria in pulmonary vascular remodeling.

Authors:  Peter Dromparis; Gopinath Sutendra; Evangelos D Michelakis
Journal:  J Mol Med (Berl)       Date:  2010-08-24       Impact factor: 4.599

Review 3.  Metabolism strikes back: metabolic flux regulates cell signaling.

Authors:  Christian M Metallo; Matthew G Vander Heiden
Journal:  Genes Dev       Date:  2010-12-15       Impact factor: 11.361

Review 4.  The structure and allosteric regulation of glutamate dehydrogenase.

Authors:  Ming Li; Changhong Li; Aron Allen; Charles A Stanley; Thomas J Smith
Journal:  Neurochem Int       Date:  2010-11-09       Impact factor: 3.921

Review 5.  A message emerging from development: the repression of mitochondrial beta-F1-ATPase expression in cancer.

Authors:  José M Cuezva; María Sánchez-Aragó; Sandra Sala; Amaya Blanco-Rivero; Alvaro D Ortega
Journal:  J Bioenerg Biomembr       Date:  2007-06       Impact factor: 2.945

6.  Proteomic and functional consequences of hexokinase deficiency in glucose-repressible Kluyveromyces lactis.

Authors:  Nadia Mates; Karina Kettner; Falk Heidenreich; Theresia Pursche; Rebekka Migotti; Günther Kahlert; Eberhard Kuhlisch; Karin D Breunig; Wolfgang Schellenberger; Gunnar Dittmar; Bernard Hoflack; Thomas M Kriegel
Journal:  Mol Cell Proteomics       Date:  2014-01-16       Impact factor: 5.911

Review 7.  Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen.

Authors:  Peter L Pedersen
Journal:  J Bioenerg Biomembr       Date:  2007-06       Impact factor: 2.945

8.  Cytometric assessment of DNA damage by exogenous and endogenous oxidants reports aging-related processes.

Authors:  Hong Zhao; Toshiki Tanaka; H Dorota Halicka; Frank Traganos; Miroslaw Zarebski; Jurek Dobrucki; Zbigniew Darzynkiewicz
Journal:  Cytometry A       Date:  2007-11       Impact factor: 4.355

9.  Direct inhibition of hypoxia-inducible transcription factor complex with designed dimeric epidithiodiketopiperazine.

Authors:  Katherine M Block; Hui Wang; Lajos Z Szabó; Nathan W Polaske; Laura K Henchey; Ramin Dubey; Swati Kushal; Csaba F László; Joshua Makhoul; Zuohe Song; Emmanuelle J Meuillet; Bogdan Z Olenyuk
Journal:  J Am Chem Soc       Date:  2009-12-23       Impact factor: 15.419

10.  Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate.

Authors:  Shanta Dhar; Stephen J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.